The Effects of Sertraline on Depression in Parkinson's Disease
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The aim of this open-label, self-control study is to evaluate the efficacy of sertraline in
treating depression in Patients with Parkinson's disease. In addition, the investigators also
want to find out whether patient gets better quality of life when depression is improved.